Comparison of Xpert CT/NG assay with Gram’s staining and culture for identifying Neisseria gonorrhoeae

Main Article Content

Anugoon Bunkhong
Patompong Yampun
Supanat Promploy

Abstract

Gonorrhoea is one of the most important sexually transmitted diseases (STDs). There are high incidence in adolescents in Thailand. This disease is caused by the fastidious bacteria, called Neisseria gonorrhoeae. In these days, the molecular biological assay, Xpert CT/NG, has been used to diagnose N. gonorrhoeae from urine specimen. The objective of this study was to compare N. gonorrhoeae detection between the Xpert CT/NG assay and the conventional assays, Gram staining and culture. 81 patients got laboratory tests for diagnosis of gonorrhoea at STDs clinic of the Office of Disease Prevention and Control region 3, Nakhon Sawan from May 2020 to January 2021. The Xpert CT/NG assay, Gram staining and culture yielded 40 positive samples (49.4%, 95% CI 38.5% - 60.3%), 33 positive samples (40.7%, 95% CI 30.0% - 51.4%) and 27 positive samples (33.3%, 95% CI 23.0% - 43.6%), respectively. For the concordance between the Xpert CT/NG assay with Gram staining and culture, % agreement and kappa were 91.4%, 0.83 and 84.0, 0.68, respectively. The mean of the Xpert CT/NG turnaround time was 1.1 days. The advantages of the Xpert CT/NG assay were high detection rate of N. gonorrhoeae, rapid testing and easy sample collection. Because of the expensive cost, the Xpert CT/NG assay should be additional test of conventional assays to reduce false negative and increase more accurate results.

Article Details

How to Cite
1.
Bunkhong A, Yampun P, Promploy S. Comparison of Xpert CT/NG assay with Gram’s staining and culture for identifying Neisseria gonorrhoeae. JDPC3 [Internet]. 2022 Nov. 29 [cited 2024 Mar. 28];16(3):26-37. Available from: https://he01.tci-thaijo.org/index.php/JDPC3/article/view/254840
Section
OriginalArticle

References

World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Geneva: WHO; 2021.

Tien V, Punjabi C, Holubar MK. Antimicrobial resistance in sexually transmitted infections. J Travel Med 2020; 27(1): taz101.

European Centre for Disease Prevention and Control. Rapid risk assessment: extensively drug-resistant (XDR) Neisseria gonorrhoeae in the United Kingdom and Australia [Internet]. [cited 2022 Jan 14]. Available from: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-extensively-drug-resistant-xdr-neisseria-gonorrhoeae-united

สำนักระบาดวิทยา. ระบบรายงานการเฝ้าระวังโรค 506 [อินเตอร์เน็ต]. [เข้าถึงเมื่อ 14 ม.ค. 2565]. เข้าถึงได้จาก: http://doe.moph.go.th/surdata/506wk/y64/d38_5164.pdf

Otero-Guerra L, Fernández-Blázquez A, Vazquez F. Rapid diagnosis of sexually transmitted infections. Enferm Infecc Microbiol Clin 2017; 35(7): 444-50.

Vickerman P, Peeling RW, Watts C, Mabey D. Detection of gonococcal infection: pros and cons of a rapid test. Mol Diagn 2005; 9(4): 175-9.

กลุ่มบางรักโรคติดต่อทางเพศสัมพันธ์ กองโรคเอดส์และโรคติดต่อทางเพศสัมพันธ์ กรมควบคุมโรค. คู่มือการตรวจวินิจฉัยโรคหนองในทางห้องปฏิบัติการทางการแพทย์. กรุงเทพฯ: สำนักพิมพ์อักษรกราฟฟิคแอนด์ดีไซน์; 2563.

Cepheid. Xpert® CT/NG package insert. USA: Cepheid; 2019.

Gordis L. Epidemiology. 5th ed. Philadelphia (PA): Elsevier Saunders; 2013.

Unemo M, Seifert HS, Hook III EW, Hawkes S, Ndowa F, Dillon JAR, Gonorrhoea. Nat Rev Dis Primers 2019 Nov 21; 5(1): 79.

Papp JR, Schachter J, Gaydos CA, Van Der Pol B. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae-2014. MMWR Recomm Rep 2014; 63: 1-19.

Situ SF, Ding CH, Nawi S, Jonar A, Ramli R. Conventional versus molecular detection of Chlamydia trachomatis and Neisseria gonorrhoeae among males in a sexually transmitted infections clinic. Malays J Pathol 2017; 39(1): 25-31.

Han Y, Shi MQ, Jiang QP, Le WJ, Qin XL, Xiong HZ, et al. Clinical performance of the Xpert® CT/NG test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae: a multicenter evaluation in Chinese urban hospitals. Front Cell Infect Microbiol 2022; 11: 784610.

Xie TA, Liu YL, Meng RC, Liu XS, Fang KY, Deng ST, et al. Evaluation of the diagnostic efficacy of Xpert CT/NG for Chlamydia trachomatis and Neisseria gonorrhoeae. BioMed Res Int 2020; 2892734.

Kueakulpattana N, Wannigama DL, Luk-in S, Hongsing P, Hurst C, Badavath VN, et al. Multidrug-resistant Neisseria gonorrhoeae infection in heterosexual men with reduced susceptibility to ceftriaxone, first report in Thailand. Sci Rep 2021; 11: 21659.

Adamson PC, Van Le H, Le HHL, Le GM, Nguyen TV, Klausner JD. Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017–2019. BMC Infect Dis 2020; 20: 809.

Fletcher-Lartey S, Dronavalli M, Alexander K, Ghosh S, Boonwaat L, Thomas J, et al. Trends in antimicrobial resistance patterns in Neisseria gonorrhoeae in Australia and New Zealand: a meta-analysis and systematic review. Antibiotics 2019; 8(4): 191.

Witkin SS, Minis E, Athanasiou A, Leizer J, Linhares IM. Chlamydia trachomatis: the persistent pathogen. Clin Vaccine Immunol 2017; 24(10): e00203-17.

Sarier M, Kukul E. Classification of non-gonococcal urethritis: a review. Int Urol Nephrol 2019; 51(6): 901-7.

Bradshaw CS, Tabrizi SN, Read TRH, Garland SM, Hopkins CA, Moss LM, et al. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis 2006; 193(3): 336-45.

Minof GRG. A new gold standard for the detection of Chlamydia trachomatis? Infect Dis Obstet Gynecol 1998; 6(1): 44–5.

Shao L, Guo Y, Jiang Y, Liu Y, Wang M, You C, Quanzhong Liu Q. Sensitivity of the standard Chlamydia trachomatis culture method is improved after one additional in vitro passage. J Clin Lab Anal. 2016; 30(5): 697–701.

Shannon CL, Klausne JD, The growing epidemic of sexually transmitted infections in adolescents: a neglected population. Curr Opin Pediatr 2018; 30(1): 137–43.